Within the past year, generative AI (genAI) has impacted nearly every industry, and healthcare is no exception. Even so, industry leaders emphasize that genAI is not a replacement for human thought, medical analysis, or medical advice.
According to a paper published in June 2023, “The Emerging Role of Generative Artificial Intelligence in Medical Education, Research, and Practice,” genAI performed several feats: It could predict renal illness, generate radiology reports, and predict the development of hematological disorders.
The paper’s authors cautioned that ChatGPT “has a limited role in critical thinking or making moral or ethical decisions.” genAI tools lack a sociocultural background, and despite being relatively context-aware, they are “not trained to make difficult, contextual, evidence-based medical decisions when it comes to clinical decision-making for a fictional patient with common symptoms.” Most damagingly, the paper reported that current genAI tools have made biased and discriminatory statements based on currently available data.
However, the above drawbacks have been accompanied by successes. ChatGPT, which debuted to great fanfare in late 2022, has become an efficient and inexpensive addition to customer services offerings. According to the June 2023 report in Cureus, a specialized genAI can summarize patient data and provide well-written notes in standard English. Generative AI chatbots can also handle customer concerns and produce helpful responses.
Below are some business benefits of genAI tools, as applied to healthcare: